PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 16 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $7,112,000 | -2.4% | 7,007,000 | 0.0% | 0.26% | -0.8% |
Q4 2021 | $7,290,000 | -0.3% | 7,007,000 | 0.0% | 0.26% | -16.7% |
Q3 2021 | $7,311,000 | -3.1% | 7,007,000 | 0.0% | 0.31% | -0.3% |
Q2 2021 | $7,544,000 | -6.4% | 7,007,000 | 0.0% | 0.31% | -5.7% |
Q1 2021 | $8,057,000 | -10.6% | 7,007,000 | 0.0% | 0.33% | -4.1% |
Q4 2020 | $9,010,000 | +13.4% | 7,007,000 | 0.0% | 0.34% | -8.2% |
Q3 2020 | $7,947,000 | +20.9% | 7,007,000 | +23.9% | 0.38% | +1.1% |
Q2 2020 | $6,574,000 | +240.1% | 5,657,000 | +223.3% | 0.37% | +235.1% |
Q2 2019 | $1,933,000 | -6.7% | 1,750,000 | -12.5% | 0.11% | -10.5% |
Q1 2019 | $2,072,000 | -30.8% | 2,000,000 | -33.3% | 0.12% | -38.3% |
Q4 2018 | $2,993,000 | +505.9% | 3,000,000 | +500.0% | 0.20% | +773.9% |
Q2 2018 | $494,000 | – | 500,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |